ID: ALA2396942

Max Phase: Preclinical

Molecular Formula: C13H17ClN6O

Molecular Weight: 272.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC1(C)N=C(N)N=C(N)N1c1cccc(OCC#N)c1.Cl

Standard InChI:  InChI=1S/C13H16N6O.ClH/c1-13(2)18-11(15)17-12(16)19(13)9-4-3-5-10(8-9)20-7-6-14;/h3-5,8H,7H2,1-2H3,(H4,15,16,17,18);1H

Standard InChI Key:  SXNPGOIGGYMOGD-UHFFFAOYSA-N

Associated Targets(Human)

Growth factor receptor-bound protein 2 663 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 272.31Molecular Weight (Monoisotopic): 272.1386AlogP: 0.77#Rotatable Bonds: 3
Polar Surface Area: 113.02Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.15CX LogP: 0.48CX LogD: -0.34
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.84Np Likeness Score: -1.12

References

1. Simister PC, Luccarelli J, Thompson S, Appella DH, Feller SM, Hamilton AD..  (2013)  Novel inhibitors of a Grb2 SH3C domain interaction identified by a virtual screen.,  21  (14): [PMID:23182216] [10.1016/j.bmc.2012.10.023]

Source